(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 71.32% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and while it is forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Invivyd's revenue in 2025 is $46,210,000.On average, 5 Wall Street analysts forecast IVVD's revenue for 2025 to be $6,163,686,633, with the lowest IVVD revenue forecast at $5,321,845,956, and the highest IVVD revenue forecast at $7,392,387,161. On average, 5 Wall Street analysts forecast IVVD's revenue for 2026 to be $17,765,517,463, with the lowest IVVD revenue forecast at $4,897,982,119, and the highest IVVD revenue forecast at $33,355,248,618.
In 2027, IVVD is forecast to generate $27,624,436,533 in revenue, with the lowest revenue forecast at $4,686,050,200 and the highest revenue forecast at $44,918,994,177.